Literature DB >> 26962224

Ion Channel Function and Cross-Species Determinants in Viral Assembly of Nonprimate Hepacivirus p7.

Stephanie Walter1, Alexander Bollenbach1, Juliane Doerrbecker1, Stephanie Pfaender1, Richard J P Brown1, Gabrielle Vieyres1, Claire Scott2, Richard Foster2, Abhinav Kumar3, Nicole Zitzmann3, Stephen Griffin2, François Penin4, Thomas Pietschmann1, Eike Steinmann5.   

Abstract

UNLABELLED: Nonprimate hepacivirus (NPHV), the closest homolog of hepatitis C virus (HCV) described to date, has recently been discovered in horses. Even though the two viruses share a similar genomic organization, conservation of the encoded hepaciviral proteins remains undetermined. The HCV p7 protein is localized within endoplasmic reticulum (ER) membranes and is important for the production of infectious particles. In this study, we analyzed the structural and functional features of NPHV p7 in addition to its role during virus assembly. Three-dimensional homology models for NPHV p7 using various nuclear magnetic resonance spectroscopy (NMR) structures were generated, highlighting the conserved residues important for ion channel function. By applying a liposome permeability assay, we observed that NPHV p7 exhibited liposome permeability features similar to those of HCV p7, indicative of similar ion channel activity. Next, we characterized the viral protein using a p7-based trans-complementation approach. A similar subcellular localization pattern at the ER membrane was observed, although production of infectious particles was likely hindered by genetic incompatibilities with HCV proteins. To further characterize these cross-species constraints, chimeric viruses were constructed by substituting different regions of HCV p7 with NPHV p7. The N terminus and transmembrane domains were nonexchangeable and therefore constitute a cross-species barrier in hepaciviral assembly. In contrast, the basic loop and the C terminus of NPHV p7 were readily exchangeable, allowing production of infectious trans-complemented viral particles. In conclusion, comparison of NPHV and HCV p7 revealed structural and functional homology of these proteins, including liposome permeability, and broadly acting determinants that modulate hepaciviral virion assembly and contribute to the host-species barrier were identified. IMPORTANCE: The recent discovery of new relatives of hepatitis C virus (HCV) enables for the first time the study of cross-species determinants shaping hepaciviral pathogenesis. Nonprimate hepacivirus (NPHV) was described to infect horses and represents so far the closest homolog of HCV. Both viruses encode the same viral proteins; however, NPHV protein functions remain poorly understood. In this study, we aimed to dissect NPHV p7 on a structural and functional level. By using various NMR structures of HCV p7 as templates, three-dimensional homology models for NPHV p7 were generated, highlighting conserved residues that are important for ion channel function. A p7-based trans-complementation approach and the construction of NPHV/HCV p7 chimeric viruses showed that the N terminus and transmembrane domains were nonexchangeable. In contrast, the basic loop and the C terminus of NPHV p7 were readily exchangeable, allowing production of infectious viral particles. These results identify species-specific constraints as well as exchangeable determinants in hepaciviral assembly.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26962224      PMCID: PMC4859704          DOI: 10.1128/JVI.00132-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Life and death of a signal peptide.

Authors:  G von Heijne
Journal:  Nature       Date:  1998-11-12       Impact factor: 49.962

Review 2.  The signal peptide.

Authors:  G von Heijne
Journal:  J Membr Biol       Date:  1990-05       Impact factor: 1.843

Review 3.  New hepatitis C therapies: the toolbox, strategies, and challenges.

Authors:  Jean-Michel Pawlotsky
Journal:  Gastroenterology       Date:  2014-03-12       Impact factor: 22.682

Review 4.  Surveying the global virome: identification and characterization of HCV-related animal hepaciviruses.

Authors:  Troels K H Scheel; Peter Simmonds; Amit Kapoor
Journal:  Antiviral Res       Date:  2014-12-26       Impact factor: 5.970

5.  Serology-enabled discovery of genetically diverse hepaciviruses in a new host.

Authors:  Peter D Burbelo; Edward J Dubovi; Peter Simmonds; Jan L Medina; Jose A Henriquez; Nischay Mishra; Jason Wagner; Rafal Tokarz; John M Cullen; Michael J Iadarola; Charles M Rice; W Ian Lipkin; Amit Kapoor
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

6.  Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras.

Authors:  Thomas Pietschmann; Artur Kaul; George Koutsoudakis; Anna Shavinskaya; Stephanie Kallis; Eike Steinmann; Karim Abid; Francesco Negro; Marlene Dreux; Francois-Loic Cosset; Ralf Bartenschlager
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

7.  Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate.

Authors:  Zhen-yong Keck; Jinming Xia; Yong Wang; Wenyan Wang; Thomas Krey; Jannick Prentoe; Thomas Carlsen; Angela Ying-Jian Li; Arvind H Patel; Stanley M Lemon; Jens Bukh; Felix A Rey; Steven K H Foung
Journal:  PLoS Pathog       Date:  2012-04-12       Impact factor: 6.823

8.  Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource.

Authors:  Donald B Smith; Jens Bukh; Carla Kuiken; A Scott Muerhoff; Charles M Rice; Jack T Stapleton; Peter Simmonds
Journal:  Hepatology       Date:  2014-01       Impact factor: 17.425

9.  Evidence for novel hepaciviruses in rodents.

Authors:  Jan Felix Drexler; Victor Max Corman; Marcel Alexander Müller; Alexander N Lukashev; Anatoly Gmyl; Bruno Coutard; Alexander Adam; Daniel Ritz; Lonneke M Leijten; Debby van Riel; Rene Kallies; Stefan M Klose; Florian Gloza-Rausch; Tabea Binger; Augustina Annan; Yaw Adu-Sarkodie; Samuel Oppong; Mathieu Bourgarel; Daniel Rupp; Bernd Hoffmann; Mathias Schlegel; Beate M Kümmerer; Detlev H Krüger; Jonas Schmidt-Chanasit; Alvaro Aguilar Setién; Veronika M Cottontail; Thiravat Hemachudha; Supaporn Wacharapluesadee; Klaus Osterrieder; Ralf Bartenschlager; Sonja Matthee; Martin Beer; Thijs Kuiken; Chantal Reusken; Eric M Leroy; Rainer G Ulrich; Christian Drosten
Journal:  PLoS Pathog       Date:  2013-06-20       Impact factor: 6.823

10.  Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly.

Authors:  Nicole Appel; Margarita Zayas; Sven Miller; Jacomine Krijnse-Locker; Torsten Schaller; Peter Friebe; Stephanie Kallis; Ulrike Engel; Ralf Bartenschlager
Journal:  PLoS Pathog       Date:  2008-03-28       Impact factor: 6.823

View more
  3 in total

1.  Immune protection against reinfection with nonprimate hepacivirus.

Authors:  Stephanie Pfaender; Stephanie Walter; Elena Grabski; Daniel Todt; Janina Bruening; Inés Romero-Brey; Theresa Gather; Richard J P Brown; Kerstin Hahn; Christina Puff; Vanessa M Pfankuche; Florian Hansmann; Alexander Postel; Paul Becher; Volker Thiel; Ulrich Kalinke; Bettina Wagner; Ralf Bartenschlager; Wolfgang Baumgärtner; Karsten Feige; Thomas Pietschmann; Jessika M V Cavalleri; Eike Steinmann
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-08       Impact factor: 11.205

2.  Roles of the 5' Untranslated Region of Nonprimate Hepacivirus in Translation Initiation and Viral Replication.

Authors:  Tomohisa Tanaka; Teruhime Otoguro; Atsuya Yamashita; Hirotake Kasai; Takasuke Fukuhara; Yoshiharu Matsuura; Kohji Moriishi
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

3.  NS2 proteases from hepatitis C virus and related hepaciviruses share composite active sites and previously unrecognized intrinsic proteolytic activities.

Authors:  Célia Boukadida; Matthieu Fritz; Brigitte Blumen; Marie-Laure Fogeron; François Penin; Annette Martin
Journal:  PLoS Pathog       Date:  2018-02-07       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.